FDA Warning Letter — Levity

Case 717990 — FEI 3040747648

The FDA took a Warning Letter action against Levity on Feb 20, 2026 (Lewes, DE). The action was issued by CDER and concerns drugs products.

Action details

Facility
Levity
Date
Feb 20, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Lewes, DE (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.